AstraZeneca’s equity investment in Summit Therapeutics comes with plans for clinical trial collaborations. The deal brings ...

Tiny Health's Series B round was led by B Capital, with participation from Spero Ventures, The Venture City, Overwater Ventures, Black Opal Ventures, Denver Ventures, Pave Health Ventures, Alumni ...

DreaMed Diabetes has received FDA 510(K) clearance for MODI, a mobile app that uses CGM (continuous glucose monitoring) data ...

Mirum Pharmaceuticals’ Atebrioz is the third FDA-approved drug for fibrodysplasia ossificans progressiva (FOP), but it brings ...

On Tuesday, a startup aiming to help healthcare practices better manage their financial and back-office operations announced that it has raised $187 million in capital in the past six months. The New ...

Merck now has global rights to a SciBrunch Therapeutics drug candidate designed to block mutated versions of the ...

While SUD affects people across all demographics, a growing body of research and clinical experience makes one point clear: ...

The next evolution in ADHD therapy needs to focus not only on drug efficacy but also on how treatment aligns with the ...

When drug prices are too high for patients, physicians take on additional workload to find solutions. A newly released 2026 ...

Novartis is acquiring a Sironax platform technology designed to transport a range of drug modalities across the protective ...

Pelago launched a behavioral health platform that integrates substance use, mental health and behavioral addiction care, ...

Hospitals' operating margins fell to 1.4% in July, down from 2.2% in May and June, according to new data from Kaufman Hall.